RxDoctor Payments Data

Cecilia Davis

Nurse Practitioner · Austin, TXNPI 1457825747

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $255,815 of the $261,658 with a category attached, or 97.8%. AbbVie accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $74,702 and has fallen 65.9% since, to $25,452 in 2025. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$261,658in general payments, 2019–2025

Across 253 payments — averaging $1034.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$261K
  • Galderma Laboratories, L.p.$344
  • Merz North America, Inc.$139

What the payments were for

  • Speaking & faculty fees$255,81598%
  • Travel & lodging$2,5101%
  • Food & beverage$3,3331%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)234$261,175
Galderma Laboratories, L.p.12$344
Merz North America, Inc.7$139

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$261,658 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Other nurse practitioner in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →